The cardiovascular effects of eplerenone, a selective aldosterone-receptor antagonist

Publisher： Elsevier

ISSN： 0149-2918

Source： Clinical Therapeutics, Vol.25, Iss.11, 2003-11, pp. : 2647-2668

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Polymorphism of interleukin-1 receptor antagonist gene and obesity

By Um J.-Y. Lee K.-M. Kim H.-M.

Clinica Chimica Acta, Vol. 340, Iss. 1, 2004-02 ,pp. : 173-177

Elsevier

Access to resources Recommend Favorite

The Prospect of Treating Rheumatoid Arthritis with Recombinant Human Interleukin-1 Receptor Antagonist

By Bresnihan B.

BioDrugs, Vol. 15, Iss. 2, 2001-02 ,pp. : 87-97

Adis International

Access to resources Recommend Favorite

Receptor-Selective Retinoids for Psoriasis: Focus on Tazarotene

By Weindl Günther

American Journal of Clinical Dermatology, Vol. 7, Iss. 2, 2006-01 ,pp. : 85-97

Adis International

Access to resources Recommend Favorite

Cardiovascular

The Genesis Report/DX, Vol. 8, Iss. 4, 1999-01 ,pp. : 28-30

Adis International

Access to resources Recommend Favorite

Differential effect of benzydamine on pro- versus anti-inflammatory cytokine production: lack of inhibition of interleukin-10 and interleukin-1 receptor antagonist

By Sironi M.

International Journal of Clinical & Laboratory Research, Vol. 30, Iss. 1, 2000-03 ,pp. : 17-19

Springer Publishing Company

Access to resources Recommend Favorite